Table 2.
Comorbidities of patients with pre-existing diabetes (group 1) and patients with newly detected diabetes after COVID-19 (group 2).
| Comorbidities | Total (n = 100) | Group 1 (n = 72) | Group 2 (n = 28) |
|---|---|---|---|
| Hypertension | 49 (49.0) | 37 (51.4) | 12 (42.9) |
| Dyslipidaemia | 13 (13.0) | 11 (15.2) | 2 (7.2) |
| Coronary artery disease (CAD) | 3 (3.0) | 3 (4.2) | 0 (0.0) |
| Primary hypothyroidism | 5 (5.0) | 4 (7.0%) | 1 (6.7%) |
| Chronic kidney disease (CKD) | 2 (2.0) | 2 (2.8) | 0 (0.0) |
Patient was considered to have hypertension if the blood pressure was ≥140/90 mmHg, if the patient was taking anti-hypertensive drugs or if there was positive medical history. Dyslipidemia was defined as positive medical history, use of lipid-lowering drugs or if the serum low density lipoprotein (LDL) cholesterol level was >100 mg/dL. Hypothyroidism was defined as positive medical history, use of thyroxine or if the serum TSH level was >10 mIU/L. Established CAD was defined as a positive history of angioplasty and/or coronary artery bypass graft surgery. Chronic kidney disease was defined as estimated glomerular filtration rate <60 ml/min/1.722.